Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $68.5 Million - $74.8 Million
-474,300 Reduced 99.31%
3,300 $482,000
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $4.52 Million - $4.74 Million
-29,100 Reduced 5.74%
477,600 $75.6 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $47.5 Million - $51.9 Million
326,400 Added 181.03%
506,700 $79.4 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $26.1 Million - $29.3 Million
-167,800 Reduced 48.2%
180,300 $28.1 Million
Q2 2023

Aug 15, 2023

BUY
$154.35 - $166.11 $26.8 Million - $28.9 Million
173,700 Added 99.6%
348,100 $57.6 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $22.3 Million - $26.6 Million
147,500 Added 548.33%
174,400 $27 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $78 Million - $87.6 Million
-487,100 Reduced 94.77%
26,900 $4.75 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $82.4 Million - $91.7 Million
510,889 Added 16422.02%
514,000 $84 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $199,977 - $221,165
-1,189 Reduced 27.65%
3,111 $552,000
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $2.48 Million - $2.82 Million
-15,711 Reduced 78.51%
4,300 $762,000
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $14 Million - $15.6 Million
-91,500 Reduced 82.05%
20,011 $3.29 Million
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $2.71 Million - $3.12 Million
19,801 Added 21.59%
111,511 $175,000
Q3 2020

Nov 05, 2020

BUY
$140.38 - $153.83 $8.89 Million - $9.74 Million
63,300 Added 222.81%
91,710 $400,000
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $1.02 Million - $1.23 Million
7,910 Added 38.59%
28,410 $130,000
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $2.28 Million - $3.16 Million
20,500 New
20,500 $242,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.